Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125481492 | 12548149 | 2 | F | 20160823 | 20160712 | 20160907 | PER | US-009507513-1606USA008289 | MERCK | 0.00 | F | Y | 104.31000 | KG | 20160907 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125481492 | 12548149 | 1 | PS | JANUMET XR | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 50/1000 MG, BID | 22044 | 1 | DF | PROLONGED-RELEASE TABLET | BID | ||||||
125481492 | 12548149 | 2 | C | PRESERVISION AREDS 2 | 2 | 1 DF, BID | U | 0 | 1 | DF | BID | ||||||||
125481492 | 12548149 | 3 | C | CARVEDILOL. | CARVEDILOL | 1 | 3.125 MG, QD | U | 0 | QD | |||||||||
125481492 | 12548149 | 4 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 20 MEQ, QD | U | 0 | 20 | MEQ | QD | |||||||
125481492 | 12548149 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | TABLET | QD | |||||
125481492 | 12548149 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MG, QD | U | 0 | 300 | MG | QD | |||||||
125481492 | 12548149 | 7 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 20 MG, QD | U | 0 | 20 | MG | CAPSULE | QD | ||||||
125481492 | 12548149 | 8 | C | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | CAPSULE | QD | |||||
125481492 | 12548149 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, QD | U | 0 | 81 | MG | TABLET | QD | ||||||
125481492 | 12548149 | 10 | C | LOMOTIL (atropine sulfate (+) diphenoxylate hydrochloride) | 2 | 2.5/0.025 MG ONCE DAILY, PRN | U | 0 | |||||||||||
125481492 | 12548149 | 11 | C | HUMALOG MIX 75/25 | 2 | 100 UNIT, 8CC INSULIN INJECTION | U | 0 | INJECTION | ||||||||||
125481492 | 12548149 | 12 | C | PRINIVIL | LISINOPRIL | 1 | 20 MG, QD | U | 0 | 20 | MG | TABLET | QD | ||||||
125481492 | 12548149 | 13 | C | SERTRALINE HYDROCHLORIDE. | SERTRALINE HYDROCHLORIDE | 1 | 100 MG, QD | U | 0 | 100 | MG | QD | |||||||
125481492 | 12548149 | 14 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 400 MG, TID | U | 0 | 400 | MG | TABLET | TID | |||||
125481492 | 12548149 | 15 | C | COLESTIPOL HYDROCHLORIDE. | COLESTIPOL HYDROCHLORIDE | 1 | Oral | 1 TABLET, 3 TIMES DAILY, PRN | U | 0 | TABLET | ||||||||
125481492 | 12548149 | 16 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125481492 | 12548149 | 1 | Blood glucose increased |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125481492 | 12548149 | Diarrhoea | |
125481492 | 12548149 | Inappropriate schedule of drug administration |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |